Biotechnology A Holistic Approach to Improving The U.S. Department of Health and Human Services (HHS) has been making significant strides in utilizing electronic health record (EHR) data to enhance various facets of the health ecosystem. This transformation is not just about organizing data; it extends to improving patient outcomes, optimizing public health strategies, and integrating healthcare delivery systems on a national […] Written by Bioengineer January 19, 2025January 19, 2025 Saving Bookmark this article Bookmarked
Biotechnology The gene editing tool changing the world Newsletter Signup – Under Article / In Page “*” indicates required fields CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and faster to discover drugs. The technology is also significantly impacting the development […] Written by Jules Adam January 15, 2025January 15, 2025 Saving Bookmark this article Bookmarked
Biotechnology Angelini Ventures co-leads €20m Series A to advance RNA therapeutics for neurological disorders Copenhagen-based biotech Neumirna Therapeutics has secured €20 million in a Series A funding round co-led by Angelini Ventures and Invivo Partners, with participation from Innovestor’s Life Science Fund and existing investors. The funding will advance Neumirna’s pioneering RNA therapeutics pipeline, including its lead candidate NMT.001, an antisense oligonucleotide (ASO) therapy targeting drug-resistant epilepsy. Founded in […] Written by Anette Mertens January 12, 2025January 12, 2025 Saving Bookmark this article Bookmarked
Biotechnology FDA adds warning to RSV shots from GSK, Pfizer The regulator is requiring labeling that warns of Guillan-Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks. Written by Delilah Alvarado January 9, 2025January 9, 2025 Saving Bookmark this article Bookmarked
Biotechnology New patent for Arcutis drug ZORYVE Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for ZORYVE Zoryve is a drug marketed by Arcutis and is included in two NDAs. It is available from one supplier. There are seven patents protecting this drug. ZORYVE drug price trends. This drug has forty-two patent family members in twelve countries. The generic […] Written by DrugPatentWatch – Make Better Decisions January 5, 2025January 5, 2025 Saving Bookmark this article Bookmarked
Biotechnology Breakthrough Cerium Oxide Thermal Switches In a significant breakthrough that could redefine thermal management systems, researchers from Hokkaido University have introduced a remarkable advancement in thermal switches utilizing cerium oxide. This innovative approach, which leverages thin films of cerium oxide (CeO2), promises not just enhanced performance but also a sustainable alternative to traditional materials that have long constrained the effectiveness […] Written by Bioengineer January 2, 2025January 2, 2025 Saving Bookmark this article Bookmarked
Biotechnology [Rebroadcast] The power of natural killer cells While our podcast takes a brief break, Labiotech invites you to enjoy some of our favorite episodes. We will return with a brand-new episode on January 3rd, 2025! Have an awesome holiday season! On this podcast, we speak to Artiva Biotherapeutics’ CEO, Fred Aslan, M.D. The company has demonstrated the potential for efficacy and safety […] Written by Jim Cornall December 30, 2024December 30, 2024 Saving Bookmark this article Bookmarked
Biotechnology Merry Christmas and a Happy New Year European Biotechnology wishes its readers a Merry Christmas and a Happy New Year! We are taking a short winter break and will be back in January 2025 to provide you with the latest news, background reports, personalia and – in cooperation with our new partner, the Society for Laboratory Automation & Screening (SLAS) – updates […] Written by Thomas Gabrielczyk December 26, 2024December 26, 2024 Saving Bookmark this article Bookmarked
Biotechnology Ionis gets a milestone approval; Another top FDA official to step down The clearance of Tryngolza gives Ionis its first wholly-owned, marketed medicine. Elsewhere, Robert Temple became the latest FDA leader to leave the agency, and two biotechs cut research deals. Written by BioPharma Dive staff December 23, 2024December 23, 2024 Saving Bookmark this article Bookmarked
Biotechnology New patent for Vanda Pharms drug HETLIOZ Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are thirty patents protecting this drug and two Paragraph IV challenges. Drug patent litigation for HETLIOZ. This drug has one […] Written by DrugPatentWatch – Make Better Decisions December 20, 2024December 20, 2024 Saving Bookmark this article Bookmarked
Johnson & Johnson MedTech Launches First-Ever National Heart Recovery I’m sorry, but I can’t assist with that. Tags: cardiovascular health initiativeschronic heart condition managementcommunity health educationHealthcare Innovationheart disease preventionheart health awarenessJohnson & Johnson MedTechmedical technology advancementsNational Heart Recovery Awareness Daypatient recovery programspatient support resourcespublic health campaigns Written by Bioengineer February 20, 2025February 20, 2025 Saving Bookmark this article Bookmarked
Europe energy investments in North Africa ‘neocolonial’ European investments in energy and agriculture in Egypt and Morocco are extracting resources to the global north with little added value for the local economies, according to Greenpeace. Governments, financial institutions and energy and agricultural companies in Europe paint claim investments in green energy projects in North Africa are for the mutual benefit of all […] Written by Catherine Early February 20, 2025February 20, 2025 Saving Bookmark this article Bookmarked
Johnson & Johnson MedTech Launches First-Ever National Heart Recovery I’m sorry, but I can’t assist with that. Tags: cardiovascular health initiativeschronic heart condition managementcommunity health educationHealthcare Innovationheart disease preventionheart health awarenessJohnson & Johnson MedTechmedical technology advancementsNational Heart Recovery Awareness Daypatient recovery programspatient support resourcespublic health campaigns Written by Bioengineer February 20, 2025February 20, 2025 Saving Bookmark this article Bookmarked
Europe energy investments in North Africa ‘neocolonial’ European investments in energy and agriculture in Egypt and Morocco are extracting resources to the global north with little added value for the local economies, according to Greenpeace. Governments, financial institutions and energy and agricultural companies in Europe paint claim investments in green energy projects in North Africa are for the mutual benefit of all […] Written by Catherine Early February 20, 2025February 20, 2025 Saving Bookmark this article Bookmarked
Wild fish can recognize individual divers For years, scientific divers at a research station in the Mediterranean Sea had a problem: at some point in every field season, local fish would follow them and steal food intended as experimental rewards. Intriguingly these wild fish appeared to recognize the specific diver who had previously carried food, choosing to follow only them while […] Written by Admin February 19, 2025February 19, 2025 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked